Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes
Ferrannini, Ele, Baldi, Simona, Frascerra, Silvia, Astiarraga, Brenno, Heise, Tim, Bizzotto, Roberto, Mari, Andrea, Pieber, Thomas R., Muscelli, Elza
Published in Diabetes (New York, N.Y.) (01.05.2016)
Published in Diabetes (New York, N.Y.) (01.05.2016)
Get full text
Journal Article
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
DeFronzo, Ralph A., Lewin, Andrew, Patel, Sanjay, Liu, Dacheng, Kaste, Renee, Woerle, Hans J., Broedl, Uli C.
Published in Diabetes care (01.03.2015)
Published in Diabetes care (01.03.2015)
Get full text
Journal Article
Canagliflozin: Effects in overweight and obese subjects without diabetes mellitus
Bays, Harold E., Weinstein, Richard, Law, Gordon, Canovatchel, William
Published in Obesity (Silver Spring, Md.) (01.04.2014)
Published in Obesity (Silver Spring, Md.) (01.04.2014)
Get full text
Journal Article
Interaction Between the Sodium‐Glucose–Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects
Wilcox, Christopher S., Shen, Wen, Boulton, David W., Leslie, Bruce R., Griffen, Steven C.
Published in Journal of the American Heart Association (20.02.2018)
Published in Journal of the American Heart Association (20.02.2018)
Get full text
Journal Article
Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin
Devineni, D., Morrow, L., Hompesch, M., Skee, D., Vandebosch, A., Murphy, J., Ways, K., Schwartz, S.
Published in Diabetes, obesity & metabolism (01.06.2012)
Published in Diabetes, obesity & metabolism (01.06.2012)
Get full text
Journal Article
The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial
Wiviott, Stephen D., Raz, Itamar, Bonaca, Marc P, Mosenzon, Ofri, Kato, Eri T, Cahn, Avivit, Silverman, Michael G, Bansilal, Sameer, Bhatt, Deepak L, Leiter, Lawrence A., McGuire, Darren K., Wilding, John PH, Gause-Nilsson, Ingrid AM, Langkilde, Anna Maria, Johansson, Peter A., Sabatine, Marc S.
Published in The American heart journal (01.06.2018)
Published in The American heart journal (01.06.2018)
Get full text
Journal Article
Effect of empagliflozin on ectopic fat stores and myocardial energetics in type 2 diabetes: the EMPACEF study
Gaborit, B., Ancel, P., Abdullah, A. E., Maurice, F., Abdesselam, I., Calen, A., Soghomonian, A., Houssays, M., Varlet, I., Eisinger, M., Lasbleiz, A., Peiretti, F., Bornet, C. E., Lefur, Y., Pini, L., Rapacchi, S., Bernard, M., Resseguier, N., Darmon, P., Kober, F., Dutour, A.
Published in Cardiovascular diabetology (01.03.2021)
Published in Cardiovascular diabetology (01.03.2021)
Get full text
Journal Article
The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus
Kasichayanula, Sreeneeranj, Liu, Xiaoni, Pe Benito, Melanie, Yao, Ming, Pfister, Marc, LaCreta, Frank P., Humphreys, William Griffith, Boulton, David W.
Published in British journal of clinical pharmacology (01.09.2013)
Published in British journal of clinical pharmacology (01.09.2013)
Get full text
Journal Article
Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairment
Macha, S., Mattheus, M., Halabi, A., Pinnetti, S., Woerle, H. J., Broedl, U. C.
Published in Diabetes, obesity & metabolism (01.03.2014)
Published in Diabetes, obesity & metabolism (01.03.2014)
Get full text
Journal Article
Dapagliflozin pharmacokinetics is similar between patients with heart failure with reduced ejection fraction and patients with type 2 diabetes mellitus
Melin, Johanna, Parkinson, Joanna, Hamrén, Bengt, Penland, Robert C., Boulton, David W., Tang, Weifeng
Published in British journal of clinical pharmacology (01.02.2024)
Published in British journal of clinical pharmacology (01.02.2024)
Get full text
Journal Article
Validation of a Novel Method for Determining the Renal Threshold for Glucose Excretion in Untreated and Canagliflozin-treated Subjects With Type 2 Diabetes Mellitus
Polidori, David, Sha, Sue, Ghosh, Atalanta, Plum-Mörschel, Leona, Heise, Tim, Rothenberg, Paul
Published in The journal of clinical endocrinology and metabolism (01.05.2013)
Published in The journal of clinical endocrinology and metabolism (01.05.2013)
Get full text
Journal Article
Semaglutide combined with empagliflozin vs. monotherapy for non-alcoholic fatty liver disease in type 2 diabetes: Study protocol for a randomized clinical trial
Lin, Yu-Hao, Zhang, Zhi-Jun, Zhong, Jin-Qing, Wang, Zhi-Yi, Peng, Yi-Ting, Lin, Yan-Mei, Zhang, Huo-Ping, Tian, Jian-Qing
Published in PloS one (03.05.2024)
Published in PloS one (03.05.2024)
Get full text
Journal Article
Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure
Wang, Dennis D., Naumova, Anna V., Isquith, Daniel, Sapp, Jamie, Huynh, Kim A., Tucker, Isabella, Balu, Niranjan, Voronyuk, Anna, Chu, Baocheng, Ordovas, Karen, Maynard, Charles, Tian, Rong, Zhao, Xue-Qiao, Kim, Francis
Published in Cardiovascular diabetology (07.06.2024)
Published in Cardiovascular diabetology (07.06.2024)
Get full text
Journal Article
Effect of empagliflozin on brachial artery shear stress and endothelial function in subjects with type 2 diabetes: Results from an exploratory study
Irace, Concetta, Cutruzzolà, Antonio, Parise, Martina, Fiorentino, Raffaella, Frazzetto, Marco, Gnasso, Chiara, Casciaro, Francesco, Gnasso, Agostino
Published in Diabetes & vascular disease research (01.01.2020)
Published in Diabetes & vascular disease research (01.01.2020)
Get full text
Journal Article
Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial
Dharmalingam, Mala, Aravind, S. R., Thacker, Hemant, Paramesh, S., Mohan, Brij, Chawla, Manoj, Asirvatham, Arthur, Goyal, Ramesh, Shembalkar, Jayashri, Balamurugan, R., Kadam, Pradnya, Alva, Hansraj, Kodgule, Rahul, Tandon, Monika, Vaidyanathan, Sivakumar, Pendse, Amol, Gaikwad, Rajesh, Katare, Sagar, Suryawanshi, Sachin, Barkate, Hanmant
Published in Drugs (New York, N.Y.) (01.04.2020)
Published in Drugs (New York, N.Y.) (01.04.2020)
Get full text
Journal Article
Renal Effects of Dapagliflozin in People with and without Diabetes with Moderate or Severe Renal Dysfunction: Prospective Modeling of an Ongoing Clinical Trial
Hallow, K. Melissa, Boulton, David W., Penland, Robert C., Helmlinger, Gabriel, Nieves, Emily H., van Raalte, Daniël H., Heerspink, Hiddo L., Greasley, Peter J.
Published in The Journal of pharmacology and experimental therapeutics (01.10.2020)
Published in The Journal of pharmacology and experimental therapeutics (01.10.2020)
Get full text
Journal Article
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study
Katakami, Naoto, Mita, Tomoya, Yoshii, Hidenori, Shiraiwa, Toshihiko, Yasuda, Tetsuyuki, Okada, Yosuke, Torimoto, Keiichi, Umayahara, Yutaka, Kaneto, Hideaki, Osonoi, Takeshi, Yamamoto, Tsunehiko, Kuribayashi, Nobuichi, Maeda, Kazuhisa, Yokoyama, Hiroki, Kosugi, Keisuke, Ohtoshi, Kentaro, Hayashi, Isao, Sumitani, Satoru, Tsugawa, Mamiko, Ryomoto, Kayoko, Taki, Hideki, Nakamura, Tadashi, Kawashima, Satoshi, Sato, Yasunori, Watada, Hirotaka, Shimomura, Iichiro
Published in Cardiovascular diabetology (09.07.2020)
Published in Cardiovascular diabetology (09.07.2020)
Get full text
Journal Article
Pharmacokinetic Evaluation of Empagliflozin in Healthy Egyptian Volunteers Using LC-MS/MS and Comparison with Other Ethnic Populations
Ayoub, Bassam M., Mowaka, Shereen, Elzanfaly, Eman S., Ashoush, Nermeen, Elmazar, Mohamed M., Mousa, Shaker A.
Published in Scientific reports (31.05.2017)
Published in Scientific reports (31.05.2017)
Get full text
Journal Article
Influence of Hepatic Impairment on the Pharmacokinetics and Safety Profile of Dapagliflozin: An Open-Label, Parallel-Group, Single-Dose Study
Kasichayanula, Sreeneeranj, Liu, Xiaoni, Zhang, Weijiang, Pfister, Marc, LaCreta, Frank P., Boulton, David W.
Published in Clinical therapeutics (01.11.2011)
Published in Clinical therapeutics (01.11.2011)
Get full text
Journal Article